Sign in

Research summary ·

Interrogating DNA methylation associated with Lewy body pathology in a cross brain-region and multi-cohort study.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This study pooled DNA methylation data from brain tissue. The samples came from several areas of the brain cortex. It used 1205 samples from 832 donors. It looked for links to a rising load of Lewy body pathology. It also compared patterns across brain diseases.

What they found

The team found 24 spots on DNA with significant differences linked to Lewy body pathology. Some were in the genes UBASH3B and PTAFR. A shared pattern was seen across Lewy body, Alzheimer's and Huntington's diseases. The top spots were specific to each disease. Differences were enriched in the region of the SNCA gene. Risk gene variants for Lewy body dementia also linked to methylation there. So did those for Parkinson's disease.

What it means for patients

The results point to changes linked to nerve cell links called synapses. The abstract does not state any use for patients. It describes patterns found in donated brain samples.

Why it is not certain yet

The abstract does not say whether these marks cause the disease. Links in pooled data are not proof of cause. The abstract gives no data on treatment. It also gives no data on people who are living.

Source

Interrogating DNA methylation associated with Lewy body pathology in a cross brain-region and multi-cohort study.

PubMed · PMID 42881165

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Lewy body dementia publications